Process for controlling hyperlipidemia
US4689326A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Oct 17, 1985 |
| Grant date | Aug 25, 1987 |
| Priority date | — |
| Expiry date | Oct 17, 2005 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D223/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A process for controlling hyperlipidemia in mammals is disclosed. In this process a hyperlipidemia controlling effective amount of a compound having structural formula: ##STR1## where R.sup.1 is hydrogen, oxo, C.sub.1 -C.sub.6 alkyl or C.sub.2 -C.sub.6 alkanoyl; R.sup.2 is hydrogen or oxo; and R.sup.3 is hydrogen, C.sub.1 -C.sub.6 alkyl, C.sub.2 -C.sub.6 alkanoyl, C.sub.2 -C.sub.6 carboxyalkyl, phenyl, benzyl or phenyl substituted with C.sub.1 -C.sub.6 alkyl, C.sub.2 -C.sub.6 alkanoyl, C.sub.1 -C.sub.6 alkoxy or halo is applied to mammals. A pharmaceutical composition comprising the above class of compounds having the meanings given herein and a pharmaceutical carrier therefor is also taught.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.